Chemical Structure (Brensocatib 01)
Brinsupri Tablet
Product Images NDC 71558-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brinsupri (NDC 71558-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Insmed Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Brensocatib 02)
Principal Display Panel (25 mg Tablet Bottle Label)
Each tablet contains 25mg of brensocatib. The recommended dosage information should be consulted. Store the tablets between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) according to USP Controlled Room Temperature guidelines. Be sure to store the tablets in their original container and keep them out of reach of children. This product is Brinsupri (brensocatib) tablets. It contains 30 tablets and is manufactured for Insmed Inc. located in Bridgewater, NJ.*
Principal Display Panel (10 mg Tablet Bottle Label)
Each tablet contains 10 mg of brensocatib. The recommended dosage can be found in the prescribing information. Store the tablets at a temperature between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). Keep the tablets in their original container and out of reach of children. This medication is Brinsupri (brensocatib) tablets. The package contains 30 tablets and is manufactured for Insmed Inc. at 700 US 202/206 Bridgewater, NJ 08807.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
